Literature DB >> 17686774

Intramolecular disulfide bond is a critical check point determining degradative fates of ATP-binding cassette (ABC) transporter ABCG2 protein.

Kanako Wakabayashi1, Hiroshi Nakagawa, Ai Tamura, Shoko Koshiba, Kazuyuki Hoshijima, Masayuki Komada, Toshihisa Ishikawa.   

Abstract

Human ABCG2 belongs to the ATP-binding cassette (ABC) transporter family and plays an important role in various biological reactions, such as xenobiotic elimination and homeostasis of protoporphyrin. We previously reported that ABCG2 exists in the plasma membrane as a homodimer bound via a disulfide bond at Cys-603. In the present study, we examined the importance of an intramolecular disulfide bond for stability of the ABCG2 protein. Substitution of either Cys-592 or Cys-608 located in the extracellular loop to glycine resulted in a significant decrease in protein levels of ABCG2 when expressed in Flp-In-293 cells. Interestingly, the protein levels of those ABCG2 variants were remarkably enhanced by treatment with the proteasome inhibitor MG132. Concomitantly, increases in ubiquitinated forms of those variant proteins were detected by immunoprecipitation. In contrast, neither the protein level nor the ubiquitinated state of the ABCG2 wild-type (WT) was affected by MG132 treatment. Ubiquitin-mediated protein degradation is suggested to be involved in degradation of misfolded ABCG2 proteins lacking the intramolecular disulfide bond. On the other hand, the protein level of ABCG2 WT increased more than 4-fold when cells were treated with bafilomycin A(1), which inhibits lysosomal degradation, whereas the C592G or C608G variant was little affected by the same treatment. These results strongly suggest that two distinct pathways exist for protein degradation of ABCG2 WT and mutants lacking the intramolecular disulfide bond. Namely, the WT ABCG2 is degraded in lysosomes, and the misfolded ABCG2 lacking intramolecular disulfide bond undergoes ubiquitin-mediated protein degradation in proteasomes.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17686774     DOI: 10.1074/jbc.C700133200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

1.  Glutathione transport is a unique function of the ATP-binding cassette protein ABCG2.

Authors:  Heather M Brechbuhl; Neal Gould; Remy Kachadourian; Wayne R Riekhof; Dennis R Voelker; Brian J Day
Journal:  J Biol Chem       Date:  2010-03-23       Impact factor: 5.157

Review 2.  Role of breast cancer resistance protein (BCRP/ABCG2) in cancer drug resistance.

Authors:  Karthika Natarajan; Yi Xie; Maria R Baer; Douglas D Ross
Journal:  Biochem Pharmacol       Date:  2012-01-11       Impact factor: 5.858

3.  Xanthines down-regulate the drug transporter ABCG2 and reverse multidrug resistance.

Authors:  Rui Ding; Jia Shi; Kirk Pabon; Kathleen W Scotto
Journal:  Mol Pharmacol       Date:  2011-11-23       Impact factor: 4.436

Review 4.  Structure and function of the human breast cancer resistance protein (BCRP/ABCG2).

Authors:  Zhanglin Ni; Zsolt Bikadi; Mark F Rosenberg; Qingcheng Mao
Journal:  Curr Drug Metab       Date:  2010-09       Impact factor: 3.731

5.  Human ABCG2: structure, function, and its role in multidrug resistance.

Authors:  Wei Mo; Jian-Ting Zhang
Journal:  Int J Biochem Mol Biol       Date:  2011-03-30

6.  Major SNP (Q141K) variant of human ABC transporter ABCG2 undergoes lysosomal and proteasomal degradations.

Authors:  Tomoka Furukawa; Kanako Wakabayashi; Ai Tamura; Hiroshi Nakagawa; Yoshihiro Morishima; Yoichi Osawa; Toshihisa Ishikawa
Journal:  Pharm Res       Date:  2008-10-29       Impact factor: 4.200

7.  Folding of matrix metalloproteinase-2 prevents endogenous generation of MHC class-I restricted epitope.

Authors:  Virginie Renaud; Emmanuelle Godefroy; Pierre Larrieu; Fabrice Fleury; Francine Jotereau; Yannick Guilloux
Journal:  PLoS One       Date:  2010-07-30       Impact factor: 3.240

8.  Dynamic vs static ABCG2 inhibitors to sensitize drug resistant cancer cells.

Authors:  Hui Peng; Jing Qi; Zizheng Dong; Jian-Ting Zhang
Journal:  PLoS One       Date:  2010-12-07       Impact factor: 3.240

Review 9.  Targeted degradation of ABC transporters in health and disease.

Authors:  Daphne Nikles; Robert Tampé
Journal:  J Bioenerg Biomembr       Date:  2007-12       Impact factor: 2.945

10.  Arginine 383 is a crucial residue in ABCG2 biogenesis.

Authors:  Orsolya Polgar; Lilangi S Ediriwickrema; Robert W Robey; Ajay Sharma; Ramanujan S Hegde; Yongfu Li; Di Xia; Yvona Ward; Michael Dean; Csilla Ozvegy-Laczka; Balazs Sarkadi; Susan E Bates
Journal:  Biochim Biophys Acta       Date:  2009-05-03
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.